Maja Mockenhaupt
- Pharmacology top 0.01%
- Drug-Induced Adverse Reactions 95
- Toxicology top 0.05%
- Pharmacovigilance and Adverse Drug Reactions 12
- Dermatology top 0.05%
- Contact Dermatitis and Allergies 26
- Chemotherapy-related skin toxicity 8
- Rheumatology top 0.1%
- Urticaria and Related Conditions 46
- Eosinophilic Disorders and Syndromes 10
- Pathology and Forensic Medicine top 0.1%
- Autoimmune Bullous Skin Diseases 53
-
- Pneumocystis jirovecii pneumonia detection and treatment 9
Maja Mockenhaupt
113 papers receiving 9.1k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Pharmacology 7.8k
- Toxicology 1.0k
- Dermatology 2.4k
- Rheumatology 4.1k
- Pathology and Forensic Medicine 3.6k
Countries citing papers authored by Maja Mockenhaupt
This map shows the geographic impact of Maja Mockenhaupt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maja Mockenhaupt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maja Mockenhaupt more than expected).
Fields of papers citing papers by Maja Mockenhaupt
This network shows the impact of papers produced by Maja Mockenhaupt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maja Mockenhaupt. The network helps show where Maja Mockenhaupt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maja Mockenhaupt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2023 | 42 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 17 | |
| 7 | 2020 | 10 | |
| 8 | 2019 | 88 | |
| 9 | 2018 | 131 | |
| 10 | [Unintended rechallenge : Generalized bullous fixed drug eruption in two elderly women]. | 2017 | 9 |
| 11 | 2015 | 12 | |
| 12 | 2009 | 53 | |
| 13 | 2009 | 46 | |
| 14 | 2008 | 14 | |
| 15 | Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Studybreakdown → | 2007 | 686 |
| 16 | Severe cutaneous adverse drug reactions. Clinical features and epidemiology | 2005 | 4 |
| 17 | 2005 | 59 | |
| 18 | 2004 | 54 | |
| 19 | 2002 | 83 | |
| 20 | Serious cutaneous adverse reactions differences in demography and past history of drug intake between Stevens-Johnson Syndrome /toxic epidermal necrolysis and generalized bullous fixed drug eruption | 1994 | 5 |
About Maja Mockenhaupt
Maja Mockenhaupt is a scholar working on Pharmacology, Dermatology and Rheumatology, having authored 119 papers that have together received 9.5k indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (95 papers), Autoimmune Bullous Skin Diseases (53 papers), Urticaria and Related Conditions (46 papers), Contact Dermatitis and Allergies (26 papers), Pharmacovigilance and Adverse Drug Reactions (12 papers), Eosinophilic Disorders and Syndromes (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers) and Chemotherapy-related skin toxicity (8 papers). The work is most often cited by research in Pharmacology (7.8k citations), Toxicology (1.0k citations) and Dermatology (2.4k citations). Maja Mockenhaupt has collaborated with scholars based in Germany, France and Italy. Frequent co-authors include Luigi Naldi, Jean‐Claude Roujeau, Peggy Sekula, Alexis Sidoroff, Ariane Dunant, Erwin Schöpf, Sima Halevy, Martin Schumacher, Berthold Rzany and Osvaldo Correia. Their work appears in journals such as New England Journal of Medicine, Nature Communications and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.